PIK3R6 and prostate carcinoma: The most strongly upregulated gene in RC43N that is annotated to RC43N 1α,25(OH)2D3-regulated NF region was PIK3R6, which recently was identified as a novel antigen in a clinical immunotherapy trial in advanced prostate cancer (52).